Skip to content

CancerIndexthe global index of cancer

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Bone Marrow Neoplasm — Research · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Hematopoietic and Lymphatic System Neoplasm
Bone Marrow Neoplasm

Cancer Family

Bone Marrow Neoplasm

CI-CAN-00000093Explore in graph →

Non-malignant1,035 active trials28 approved drugs633 evidence items

NCIt: C35370
MeSH: D019046

Overview
Statistics
Survival
Genomics18
Variants & evidence633
Drugs53
Trials4615
Research
Rankings
Sources & provenance

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Trials tab
Methodology: publication counts

Literature

Linked publications (219)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedProvenance

Source: PubMed (NLM)
Dataset: PubMed E-utilities
Retrieved: Sep 8, 2026
Layer: normalized (units and labels harmonized; values unchanged)

PublishedShowing 76–100 of 219 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Philadelphia chromosome-positive acute myeloid leukemia: cytoimmunologic and cytogenetic features.
· Haematologica · 1996 · PMID 8952155 · validated civic_curation pubmed
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.
· Blood · 2010 · PMID 20385793 · validated civic_curation pubmed
Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group.
· Blood · 2013 · PMID 23974201 · validated civic_curation pubmed
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.
· Blood · 2022 · PMID 34320176 · validated civic_curation pubmed
Prognostic impact of CEBPA bZIP domain mutation in acute myeloid leukemia.
· Blood Adv · 2022 · PMID 34448807 · validated civic_curation pubmed
CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children's Oncology Group.
· Blood · 2021 · PMID 33951732 · validated civic_curation pubmed
Fusion of two novel genes, RBM15 and MKL1, in the t(1;22)(p13;q13) of acute megakaryoblastic leukemia.
· Nat Genet · 2001 · PMID 11431691

Showing 76–100 of 219 publications

← Previous
1
2
3
4
5
…
9
Next →

· validated civic_curation

Heterogeneous cytogenetic subgroups and outcomes in childhood acute megakaryoblastic leukemia: a retrospective international study.

· Blood · 2015 · PMID 26215111 · validated civic_curation pubmed

Consistent detection of TLS/FUS-ERG chimeric transcripts in acute myeloid leukemia with t(16;21)(p11;q22) and identification of a novel transcript.

· Blood · 1997 · PMID 9242552 · validated civic_curation pubmed

Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group.

· Blood · 2018 · PMID 30150206 · validated civic_curation pubmed

The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor alpha gene to a novel transcribed locus.

· Nature · 1990 · PMID 2170850 · validated civic_curation pubmed

Rearrangements and aberrant expression of the retinoic acid receptor alpha gene in acute promyelocytic leukemias.

· J Exp Med · 1990 · PMID 2175343 · validated civic_curation pubmed

Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study.

· Blood · 2016 · PMID 27114462 · validated civic_curation pubmed

NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.

· Blood · 2014 · PMID 25145343 · validated civic_curation pubmed

Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia.

· Haematologica · 2023 · PMID 36815378 · validated civic_curation pubmed

The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.

· Nat Med · 2018 · PMID 29227476 · validated civic_curation pubmed

Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia.

· Blood Adv · 2024 · PMID 38621200 · validated civic_curation pubmed

The KMT2A recombinome of acute leukemias in 2023.

· Leukemia · 2023 · PMID 37019990 · validated civic_curation pubmed

Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.

· N Engl J Med · 2005 · PMID 15659725 · validated civic_curation pubmed

Cryptic BCR-ABL fusion gene as variant rearrangement in chronic myeloid leukemia: molecular cytogenetic characterization and influence on TKIs therapy.

· Oncotarget · 2017 · PMID 28404889 · validated civic_curation pubmed

Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9.

· Cancer Genet Cytogenet · 2009 · PMID 19737651 · validated civic_curation pubmed

Clinical impact of DNMT3A mutations in younger adult patients with acute myeloid leukemia: results of the AML Study Group (AMLSG).

· Blood · 2013 · PMID 23632886 · validated civic_curation pubmed

RAS mutation in acute myeloid leukemia is associated with distinct cytogenetic subgroups but does not influence outcome in patients younger than 60 years.

· Blood · 2005 · PMID 15951308 · validated civic_curation pubmed

Implications of NRAS mutations in AML: a study of 2502 patients.

· Blood · 2006 · PMID 16434492 · validated civic_curation pubmed

Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B.

· Haematologica · 2009 · PMID 19059939 · validated civic_curation pubmed